title: MicroRNA-modulated targeting of vascular smooth muscle cells.
abstract: VSMCs exhibit the remarkable plasticity required for development and adaptation of the cardiovascular system. The capacity of VSMCs to modulate their phenotype has evolved to facilitate angiogenesis and wound healing, but it has also been implicated in the pathogenesis of atherosclerosis, restenosis, posttransplant arteriopathy, and pulmonary hypertension. In this issue of the JCI, Boettger and colleagues report that the recently discovered Mir143/145 gene cluster promotes acquisition of the contractile phenotype of murine VSMCs (see the related article beginning on page 2634). These VSMC-restricted microRNAs, which target unique combinations of SMC genes, provide an efficient mechanism to fine-tune cardiovascular homeostasis and the response of the vessel wall to injury. This important discovery will open the door to new avenues of investigation and potentially future therapies for vascular diseases.
authors.affiliation: University of Pennsylvania Cardiovascular Institute and Department of Medicine, Philadelphia, Pennsylvania 19104, USA. michael.parmacek@uphs.upenn.edu
authors.forename: Michael S
authors.initials: MS
authors.lastname: Parmacek
mesh_terms: D000818:Animals; D001665:Binding Sites / Q000235:genetics; D002454:Cell Differentiation; D051379:Mice; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism*; D005810:Multigene Family; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism*; D010641:Phenotype
chemical_list: C543499:MIRN145a microRNA, mouse; D035683:MicroRNAs; C532884:MIRN143 microRNA, mouse
references.citation: J Clin Invest. 2009 Sep;119(9):2634-47
references.pmid: 19690389
references.citation: Physiol Rev. 2004 Jul;84(3):767-801
references.pmid: 15269336
references.citation: Nat Genet. 2006 Jun;38 Suppl:S8-13
references.pmid: 16736023
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):921-8
references.pmid: 19342595
references.citation: J Clin Invest. 2008 Feb;118(2):515-25
references.pmid: 18188448
references.citation: Genome Res. 2006 Feb;16(2):197-207
references.pmid: 16365378
references.citation: Cell. 2009 Jan 23;136(2):215-33
references.pmid: 19167326
references.citation: Circ Res. 2007 Mar 16;100(5):633-44
references.pmid: 17363709
references.citation: Dev Biol. 2005 Dec 15;288(2):502-13
references.pmid: 16310178
references.citation: Arterioscler Thromb Vasc Biol. 2009 May;29(5):622
references.pmid: 19369655
references.citation: Mol Cell Biol. 2003 Apr;23(7):2425-37
references.pmid: 12640126
references.citation: J Clin Invest. 1997 Dec 1;100(11 Suppl):S87-9
references.pmid: 9413408
references.citation: Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1596-601
references.pmid: 15231515
references.citation: Cell Stem Cell. 2008 Mar 6;2(3):219-29
references.pmid: 18371447
references.citation: J Clin Invest. 2006 Jan;116(1):36-48
references.pmid: 16395403
references.citation: Cell. 2007 Nov 30;131(5):861-72
references.pmid: 18035408
references.citation: Nature. 2009 Aug 6;460(7256):705-10
references.pmid: 19578358
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16570-5
references.pmid: 17940050
references.citation: Circulation. 2000 Mar 28;101(12):1372-8
references.pmid: 10736279
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9366-70
references.pmid: 12867591